<p>We performed systematic and comprehensive multi-sector immunogenomic analyses on 93 samples from a cohort of 30 patients with primary or recurrent gliomas or metastatic brain tumors, representing the largest cohort of these brain cancers studied spatially to date. For each patient, we characterized multiple spatially distinct regions using whole-exome (WES), custom capture validation, RNA, and TCR-sequencing. Our findings underscore the significant differences in clonal architecture between gliomas and metastatic brain tumors which translates into distinct neoantigen landscapes and, in turn, tumor infiltrating T cell clonotypic diversity. These data therefore provide high resolution insights into the immunogenomic landscapes within malignant brain tumors which may inform tumor-specific therapeutic approaches.</p>

Immunogenomics of Malignant Brain Tumors

1 selected publication including "Characterization of the Genomic and Immunologic Diversity of Malignant..." (45 citations)

Immunogenomics of Malignant Brain Tumors

Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis